NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q4 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q4 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Entity Common Stock, Shares Outstanding for the quarter ending December 13, 2024 was 30.8M shares, a 28.7% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 30.8M +6.88M +28.7% Dec 13, 2024 10-K 2024-12-17
Q2 2024 30.8M +6.89M +28.8% Aug 13, 2024 10-Q 2024-08-14
Q1 2024 27.5M +9.95M +56.7% May 10, 2024 10-Q 2024-05-14
Q4 2023 24M +7.72M +47.6% Dec 15, 2023 10-K 2023-12-15
Q2 2023 23.9M +7.71M +47.6% Aug 10, 2023 10-Q 2023-08-14
Q1 2023 17.6M +1.37M +8.45% May 11, 2023 10-Q 2023-05-12
Q4 2022 16.2M +50.7K +0.31% Dec 20, 2022 10-K 2022-12-22
Q2 2022 16.2M +4.21M +35.1% Aug 9, 2022 10-Q 2022-08-11
Q1 2022 16.2M +4.24M +35.5% May 11, 2022 10-Q 2022-05-12
Q4 2021 16.2M -6.81M -29.6% Dec 13, 2021 10-K/A 2022-05-31
Q2 2021 12M -10.1M -45.6% Aug 12, 2021 10-Q 2021-08-13
Q1 2021 12M -4.2M -26% May 13, 2021 10-Q 2021-05-14
Q4 2020 23M +9.3M +67.9% Dec 7, 2020 10-K 2020-12-09
Q2 2020 22.1M +8.56M +63.5% Aug 10, 2020 10-Q 2020-08-13
Q1 2020 16.2M +2.94M +22.3% May 8, 2020 10-Q 2020-05-14
Q4 2019 13.7M +3.82M +38.7% Nov 30, 2019 10-K 2019-12-20
Q2 2019 13.5M +4.03M +42.7% Aug 9, 2019 10-Q 2019-08-14
Q1 2019 13.2M +5.35M +68% May 8, 2019 10-Q 2019-05-10
Q4 2018 9.88M Nov 30, 2018 10-KT/A 2019-03-18
Q2 2018 9.46M +1.59M +20.2% Aug 8, 2018 10-Q 2018-08-13
Q1 2018 7.86M +2.79M +55% Mar 31, 2018 10-K 2018-04-16
Q3 2017 7.86M +2.79M +55% Nov 10, 2017 10-Q 2017-11-14
Q2 2017 7.86M +2.79M +55% Aug 11, 2017 10-Q 2017-08-14
Q1 2017 5.07M 0 0% Apr 14, 2017 10-K 2017-04-17
Q3 2016 5.07M 0 0% Nov 14, 2016 10-Q 2016-11-21
Q2 2016 5.07M 0 0% May 18, 2016 10-Q 2016-05-23
Q1 2016 5.07M 0 0% Apr 11, 2016 10-K 2016-04-14
Q3 2015 5.07M Nov 13, 2015 10-Q 2015-11-16
Q2 2015 5.07M 0 0% May 18, 2015 10-Q 2015-05-20
Q1 2015 5.07M 0 0% Mar 31, 2015 10-K 2015-04-15
Q4 2014 5.07M Nov 19, 2014 10-Q 2014-11-19
Q2 2014 5.07M 0 0% May 20, 2014 10-Q 2014-05-20
Q1 2014 5.07M 0 0% Mar 31, 2014 10-K/A 2014-04-24
Q3 2013 6.57M +1.5M +29.6% Sep 30, 2013 10-Q 2013-11-15
Q2 2013 5.07M 0 0% Aug 14, 2013 10-Q 2013-08-15
Q1 2013 5.07M 0 0% Apr 11, 2013 10-K 2013-04-11
Q3 2012 5.07M +488K +10.6% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 5.07M +573K +12.7% Jun 30, 2012 10-Q 2012-08-15
Q1 2012 5.07M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 5.07M Dec 31, 2011 10-K 2012-03-28
Q3 2011 4.59M Sep 30, 2011 10-Q 2011-11-07
Q2 2011 4.5M Jun 30, 2011 10-Q/A 2011-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.